A British investor with significant holdings in 23andMe is reportedly interested in a potential rescue of the beleaguered Californian consumer genetics company. Richard Magides, director of Singapore-based Zentree Investment, holds
All posts tagged in 23andMe
2Articles
23andMe, the prominent California-based genetic testing company, has filed for Chapter 11 bankruptcy protection in the United States. The move comes as the firm seeks to secure a buyer and
